{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:17:31Z","timestamp":1725927451878},"reference-count":27,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2024.2024.0265","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T12:04:01Z","timestamp":1723205041000},"source":"Crossref","is-referenced-by-count":0,"title":["Deficiency of Adenosine Deaminase 2"],"prefix":"10.4274","author":[{"given":"\u00c7a\u011fr\u0131","family":"Co\u015fkun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eule","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-023-02721-6","article-title":"A wide spectrum of the phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review","volume":"18","author":"Maccora","year":"2023","unstructured":"1. Maccora I, Maniscalco V, Campani S, Carrera S, Abbati G, Marrani E, Mastrolia MV, Simonini G. A wide spectrum of the phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review. Orphanet J Rare Dis. 2023;18:117.","journal-title":"Orphanet J Rare Dis"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Lee PY, Davidson BA, Abraham RS, Alter B, Arostegui JI, Bell K, Belot A, Bergerson JRE, Bernard TJ, Brogan PA, Berkun Y, Deuitch NT, Dimitrova D, Georgin-Lavialle SA, Gattorno M, Grimbacher B, Hashem H, Hershfield MS, Ichord RN, Izawa K, Kanakry JA, Khubchandani RP, Klouwer FCC, Luton EA, Man AW, Meyts I, Van Montfrans JM, Ozen S, Saarela J, Santo GC, Sharma A, Soldatos A, Sparks R, Torgerson TR, Uriarte IL, Youngstein TAB, Zhou Q, Aksentijevich I, Kastner DL, Chambers EP, Ombrello AK. Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement. JAMA Netw Open. 2023;6:e2315894.","DOI":"10.1001\/jamanetworkopen.2023.15894"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","unstructured":"3. Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921-931.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","unstructured":"4. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911-920.","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis, and treatment","volume":"40","author":"Pinto","year":"2021","unstructured":"5. Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis, and treatment. Clin Rheumatol. 2021;40:3883-3896.","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"101844","DOI":"10.1016\/j.berh.2023.101844","article-title":"Deficiency of adenosine deaminase 2 (DADA2)","volume":"37","author":"Sharma","year":"2023","unstructured":"6. Sharma V, Deo P, Sharma A. Deficiency of adenosine deaminase 2 (DADA2). Best Pract Res Clin Rheumatol. 2023;37:101844.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-020-00944-1","article-title":"The many faces of monogenic autoinflammatory disease: adenosine deaminase 2 deficiency","volume":"22","author":"JL","year":"2020","unstructured":"7. Kendall JL, Springer JM. The many faces of monogenic autoinflammatory disease: adenosine deaminase 2 deficiency. Curr Rheumatol Rep. 2020;22:64.","journal-title":"Curr Rheumatol Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12722","article-title":"Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity","volume":"287","author":"Moens","year":"2019","unstructured":"8. Moens L, Hershfield M, Arts K, Aksentijevich I, Meyts I. Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity. Immunol Rev. 2019;287:62-72.","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"935957","DOI":"10.3389\/fimmu.2022.935957","article-title":"Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity","volume":"13","author":"Signa","year":"2022","unstructured":"9. Signa S, Bertoni A, Penco F, Caorsi R, Cafaro A, Cangemi G, Volpi S, Gattorno M, Schena F. Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity. Front Immunol. 2022;13:935957.","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","unstructured":"10. Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569-578.","journal-title":"J Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","unstructured":"11. Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O'Neil LJ, Liu Y, Jacobson KA, Ombrello AK, Stone DL, Tsai WL, Kastner DL, Aksentijevich I, Kaplan MJ, Grayson PC. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood. 2019;134:395-406.","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.semarthrit.2021.04.013","article-title":"The role of vascular inflammation markers in deficiency of adenosine deaminase 2","volume":"51","author":"Kaya Akca","year":"2021","unstructured":"12. Kaya Akca U, Sag E, Unal S, Kasap Cuceoglu M, Bilginer Y, Ozen S. The role of vascular inflammation markers in deficiency of adenosine deaminase 2. Semin Arthritis Rheum. 2021;51:839-844.","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","unstructured":"13. Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, M\u00fcller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, G\u00fcng\u00f6r T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I. Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol. 2021;41:1633-1647.","journal-title":"J Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"679919","DOI":"10.3389\/fphys.2021.679919","article-title":"Proerythroblast cells of Diamond-Blackfan anemia patients with RPS19 and CECR1 mutations have similar transcriptomic signature","volume":"12","author":"Karaosmanoglu","year":"2021","unstructured":"14. Karaosmanoglu B, Kursunel MA, Uckan Cetinkaya D, Gumruk F, Esendagli G, Unal S, Taskiran EZ. Proerythroblast cells of Diamond-Blackfan anemia patients with RPS19 and CECR1 mutations have similar transcriptomic signature. Front Physiol. 2021;12:679919.","journal-title":"Front Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","unstructured":"15. \u00d6zen S, Batu ED, Ta\u015fk\u0131ran EZ, \u00d6zkara HA, \u00dcnal \u015e, G\u00fcleray N, Erden A, Karada\u011f \u00d6, G\u00fcmr\u00fck F, \u00c7etin M, S\u00f6nmez HE, Bilginer Y, Ayvaz D\u00c7, Tezcan I. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol. 2020;47:117-125.","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","unstructured":"16. Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Kon\u00e9-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Med Genet. 2018;26:960-971.","journal-title":"Eur J Med Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","volume":"14","author":"Caorsi","year":"2016","unstructured":"17. Caorsi R, Penco F, Schena F, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J. 2016;14:51.","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12969-021-00535-z","article-title":"Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China","volume":"19","author":"Wang","year":"2021","unstructured":"18. Wang W, Zhang T, Zheng W, Zhong L, Wang L, Li J, Liu Q, Dong Y, Song H. Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China. Pediatr Rheumatol Online J. 2021;19:44.","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, Alosaimi MF, Stafstrom K, Platt CD, Stauber T, Raz S, Tirosh I, Weiss A, Jordan MB, Krupski C, Eleftheriou D, Brogan P, Sobh A, Baz Z, Lefranc G, Irani C, Kilic SS, El-Owaidy R, Lokeshwar MR, Pimpale P, Khubchandani R, Chambers EP, Chou J, Geha RS, Nigrovic PA, Zhou Q. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;145:1664-1672.e10.","DOI":"10.1016\/j.jaci.2019.12.908"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"869570","DOI":"10.3389\/fimmu.2022.869570","article-title":"Deficiency of human adenosine deaminase type 2-a diagnostic conundrum for the hematologist","volume":"13","author":"Pilania","year":"2022","unstructured":"20. Pilania RK, Banday AZ, Sharma S, Kumrah R, Joshi V, Loganathan S, Dhaliwal M, Jindal AK, Vignesh P, Suri D, Rawat A, Singh S. Deficiency of human adenosine deaminase type 2-a diagnostic conundrum for the hematologist. Front Immunol. 2022;13:869570.","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fped.2018.00282","article-title":"Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2","volume":"6","author":"Lee","year":"2018","unstructured":"21. Lee PY. Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2. Front Pediatr. 2018;6:282.","journal-title":"Front Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the clinical phenotype of adenosine deaminase 2 deficiency","volume":"177","author":"Ben-Ami","year":"2016","unstructured":"22. Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316-320.","journal-title":"J Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.12167","article-title":"Erythrocyte adenosine deaminase: diagnostic value for Diamond\u2010Blackfan anaemia","volume":"160","author":"Fargo","year":"2013","unstructured":"23. Fargo JH, Kratz CP, Giri N, Savage SA, Wong C, Backer K, Alter BP, Glader B. Erythrocyte adenosine deaminase: diagnostic value for Diamond\u2010Blackfan anaemia. Br J Haematol. 2013;160:547-554.","journal-title":"Br J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJM198312153092404","article-title":"Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia","volume":"309","author":"Glader","year":"1983","unstructured":"24. Glader BE, Backer K, Diamond LK. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med. 1983;309:1486-1490.","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Wlodarski MW, Vlachos A, Farrar JE, Da Costa LM, Kattamis A, Dianzani I, Belendez C, Unal S, Tamary H, Pasauliene R, Pospisilova D, de la Fuente J, Iskander D, Wolfe L, Liu JM, Shimamura A, Albrecht K, Lausen B, Bechensteen AG, Tedgard U, Puzik A, Quarello P, Ramenghi U, Bartels M, Hengartner H, Farah RA, Al Saleh M, Hamidieh AA, Yang W, Ito E, Kook H, Ovsyannikova G, Kager L, Gleizes PE, Dalle JH, Strahm B, Niemeyer CM, Lipton JM, Leblanc TM; International Diamond-Blackfan Anaemia Syndrome Guideline Panel. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement. Lancet Haematol. 2024;11:e368-e382.","DOI":"10.1016\/S2352-3026(24)00063-2"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.ab.2021.114292","article-title":"Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency","volume":"628","author":"Ito","year":"2021","unstructured":"26. Ito M, Nihira H, Izawa K, Yasumi T, Nishikomori R, Iwaki-Egawa S. Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency. Anal Biochem. 2021;628:114292.","journal-title":"Anal Biochem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18176\/jiaci.0748","article-title":"Treatment and outcome in deficiency of adenosine deaminase 2: a literature review","volume":"32","author":"Zhang","year":"2021","unstructured":"27. Zhang B, Xu N, Chen J, Zhang S, Huang X, Shen M, Zeng X. Treatment and outcome in deficiency of adenosine deaminase 2: a literature review. J Investig Allergol Clin Immunol. 2021;32:13-22.","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:32:49Z","timestamp":1725867169000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-22457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2024.0265","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"type":"print","value":"1300-7777"},{"type":"electronic","value":"1308-5263"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}